v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 1,191,282 $ 4,608,073
Accounts receivable 338,695 238,800
Contract assets 9,362
Deferred contract costs 166,841 199,380
Other current assets 426,595 595,692
Total current assets 2,123,413 5,651,307
Intangible assets, net 135,695 147,391
Goodwill 4,183,232 4,183,232
Total assets 6,442,340 9,981,930
Current Liabilities:    
Accounts payable and accrued expenses 851,904 876,168
Commission liability 5,390 4,934
Deferred revenue 384,755 477,058
Total current liabilities 1,242,049 1,358,160
Total liabilities 1,242,049 1,358,160
Commitments and Contingencies (Note 7)
Stockholders’ Equity:    
Common stock, $0.0001 par value, 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025 respectively; 16,132,487 shares issued and outstanding as of March 31, 2026 and December 31, 2025 1,613 1,613
Additional paid-in capital 201,393,571 200,353,514
Accumulated deficit (196,204,945) (191,741,409)
Accumulated comprehensive income 10,052 10,052
Total stockholders’ equity 5,200,291 8,623,770
Total liabilities and stockholders’ equity $ 6,442,340 $ 9,981,930